Document Detail


PET-measured heterogeneity in longitudinal myocardial blood flow in response to sympathetic and pharmacologic stress as a non-invasive probe of epicardial vasomotor dysfunction.
MedLine Citation:
PMID:  16639609     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: We investigated whether a myocardial perfusion gradient during pharmacologically induced hyperemia also occurred during sympathetic stimulation with cold pressor testing (CPT), which commonly induces a paradoxical coronary vasoconstriction in individuals with coronary risk factors. METHODS: Myocardial blood flow (MBF) was measured in absolute units (ml/g/min) with 13N-ammonia and PET at rest, during CPT, and during pharmacologic vasodilation in 59 participants with coronary risk factors ("at risk") and in 43 healthy individuals (controls). MBF was assessed globally as mean MBF, and in the mid and mid-distal myocardium of the left ventricle (LV). A decrease in MBF from mid to mid-distal LV myocardium was defined as MBF difference indicative of a perfusion gradient. RESULTS: The change in mean MBF to CPT (DeltaMBF) in the at-risk group was significantly reduced compared with controls (0.05+/-0.19 vs 0.31+/-0.20 ml/g/min, p<0.0001), whereas mean MBF during pharmacologic vasodilation in the at-risk group tended to be lower than in controls (1.72+/-0.71 vs 2.00+/-0.64 ml/g/min, p=NS). Absolute MBFs during CPT and pharmacologic vasodilation were significantly lower in the mid-distal than in the mid LV myocardium, resulting in a significant MBF difference in the at-risk group (0.15+/-0.06 and 0.27+/-0.12 ml/g/min, p<0.0001) that was not observed in controls (0.007+/-0.05 and 0.014+/-0.10 ml/g/min, p=NS). In the at-risk group there was a significant correlation between the difference of mid to mid-distal MBF during CPT and that during pharmacologic vasodilation (r=0.43, p<0.004), suggesting functional alterations of epicardial vessels as the predominant cause for the observed MBF difference. CONCLUSION: The relative decrease in MBF from the mid to the mid-distal left-ventricular myocardium suggests an intracoronary pressure decline during CPT and pharmacologic vasodilation, which is likely to reflect an impairment of flow-mediated epicardial vasomotor function.
Authors:
Thomas H Schindler; Alvaro D Facta; John O Prior; Roxana Campisi; Masayuki Inubushi; Michael C Kreissl; Xiao-Li Zhang; James Sayre; Magnus Dahlbom; Heinrich R Schelbert
Related Documents :
21080979 - Usefulness of ambulatory blood pressure monitoring and head-up tilt test in the evaluat...
10574399 - A critical appraisal of the rate pressure product as index of myocardial oxygen consump...
1121509 - Direct effects of hypoosmolality on vascular resistance and myocardial contractile forc...
6818339 - Local vasoactivity of oxygen and carbon dioxide in the right coronary circulation of th...
15162979 - Role of prehypertension in the development of coronary atherosclerosis in japan.
10900179 - Hyperlipidemia with hypoglycemia reduces myocardial oxygen utilization efficiency but n...
8891499 - Breath-by-breath determinations of airway occlusion pressure in the developing lamb.
10915419 - Valsartan: new preparation. just a second-line antihypertensive drug.
18384169 - Fabrication of burst pressure competent vascular grafts via electrospinning: effects of...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2006-04-26
Journal Detail:
Title:  European journal of nuclear medicine and molecular imaging     Volume:  33     ISSN:  1619-7070     ISO Abbreviation:  Eur. J. Nucl. Med. Mol. Imaging     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-09-29     Completed Date:  2007-05-01     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  101140988     Medline TA:  Eur J Nucl Med Mol Imaging     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1140-9     Citation Subset:  IM    
Affiliation:
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California at Los Angeles, 10833 Le Conte Ave, 23-120 CHS, P.O. Box 173517, Los Angeles, CA 90095-1735, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Ammonia / diagnostic use
Blood Flow Velocity
Carbon Radioisotopes / diagnostic use
Cold Temperature / diagnostic use
Coronary Circulation*
Exercise Test / methods
Female
Humans
Male
Pericardium / physiopathology*,  radionuclide imaging*
Positron-Emission Tomography / methods*
Radiopharmaceuticals / diagnostic use
Sympathetic Nervous System / physiopathology*
Vasodilator Agents / diagnostic use*
Vasomotor System / radionuclide imaging*
Grant Support
ID/Acronym/Agency:
HL 33177/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Carbon Radioisotopes; 0/Radiopharmaceuticals; 0/Vasodilator Agents; 7664-41-7/Ammonia

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Accuracy and precision of perfusion lung scintigraphy versus 133Xe-radiospirometry for preoperative ...
Next Document:  Partial volume effect correction in SPECT for striatal uptake measurements in patients with neurodeg...